VIPGC-NO
Alternative Names: 28a-Glycine-28b-(S-nitroso-L-cysteinamide)-vasoactive intestinal octacosapeptide; VIP-Gly-Cys-NOLatest Information Update: 25 Aug 2022
At a glance
- Originator La Jolla Pharmaceutical Company; Nonindustrial sources
- Class Neuropeptides
- Mechanism of Action Nitric oxide stimulants; Vasoactive intestinal peptide receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Male sexual dysfunction